Instruction for medical use
MENOKVIN contains of balanced complex of the plant hormone (estrogen and progestogen) substances, which stimulate the synthesis of its own hormones, that contributes to preventing and reducing menopausal disorders.
Cimicifuga racemosa contains triterpene glycosides, which are due to the activation receptors of the hypothalamus, reduce the release of releasing factor luteinizing hormone (LH) and reduce the secretion of LH from the anterior lobe of pituitary gland. Decrease the release of gonadotropins leads to the removing menopausal syndrome in women: hot flashes, psycho-emotional and vegetative disorders, which occurring in period of pre- and menopause.
Pueraria lobata contains miroestrol and deoxymiroestrol. Due to structural similarity with estradiol, it has high estrogenic activity. Pueraria contains of isoflavones: daidzein, daidzin and puerarin which have affinity to the estrogen receptors selectively associated primarily with β-estrogen receptors in a woman's body and show properties, that characterise an estrogens, preventing and reducing the intensity of menopausal syndrome. Pueraria isoflavones are demonstrating powerful antioxidant properties that help to reduce the tone of the vascular wall and the normalization of elevated blood pressure.
Angelica sinensis - female ginseng, contains of essential oils, macro- and microelements, phenol compounds, β-sitosterol, which activates aromatase and help raise the level of your own estrogen, exerts hypocholesterolemic, hypotensive and sedative properties.
Passiflora incarnata contains of flavonoids (vitexin, saponarin, vicenin etc.), maltol, coumarin, cyanoglucoside etc. The extract of Passiflora has sedative and antispasmodic properties at the conditions that accompanying menopause: neurasthenia, neurovegetative dystonia.
Composition and drug formulation.
30 capsules. Each capsule contains of:
- extract of the herb Passiflora incarnata - 50 mg;
- the root extract of Pueraria lobata - 50 mg;
- the root extract of Angelica sinensis - 50mg;
- the root extract of Cimicifuga racemosa - 30 mg;
Excipients: orisil, calcium stearate, lactose, microcrystalline cellulose.
Indications for use.
MENOKVIN is recommended as a dietary supplement to the diet of women in premenopausal period and climacteric syndrome for preventing and reducing the emotional, vegetative-vascular disorders (sleep disturbance, irritability, hot flashes, hyperhidrosis) and somatic disorders (dryness and itching in the genital area, hypercholesterolemia, dyspepsia).
Posology and method of adminitration.
Adults take 1 capsule 1 time a day before or during meals. Duration of use - 1 month. Before applying you must consult with a doctor.
Individual intolerance to components, pregnancy and lactation, estrogen-dependent hyperproliferative processes.
Are not detected.
Store in a dry, dark place at temperatures not above 25°C and in an inaccessible to children place. Shelf life - 2 years. Date expiry date indicated on the packaging.
PSEE №05.03.02-04/84335 from 17.09.2013
It is not a drug.
MENOKVIN is made of high quality herbal ingredients production by EUSA COLORS (France).